Pidilite Industries Limited PIDILITIND
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on PIDILITIND
Real prices, every charge counted. Pick one or write your own.Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 13 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Are its options cheap or dear?It compares the movement option prices assume with the movement the share has actually shown.
Live in market hoursImplied volatility needs the live option chain, which is open 9:15 to 3:30.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Against its sectorWhere this company ranks among similar companies on each measure.
Specialty Chemicals · 90 peers · mediansWhat the numbers sayShort plain statements about this company's latest figures.
Written by fixed rulesLatest quarterIn the quarter to September 2026 (results filed 28 Oct 2026), sales rose 20.9% from a year earlier to ₹4,298 cr and profit rose 7.2% to ₹626 cr.
- Sales grew 4 years running (₹9,921 cr in FY22 to ₹14,601 cr in FY26).
- Profit grew 4 years running (₹1,207 cr in FY22 to ₹2,471 cr in FY26).
- Operating margin rose from 16.8% in FY23 to 24.1% in FY26.
- Return on equity stayed above 15% from FY24 to FY26 (lowest 21.8%).
- Cash from operations was at least the reported profit in each of FY24, FY25, FY26.
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
How the share moved on resultsWhat the share price did around each recent quarterly result.
Over the last 20 results, the share rose on 11 and fell on 9, and moved by 3% or more on 8.
Q2 FY27: results filed 28 Oct 2026. The share went from its close on 27 Oct 2026 to its close on 29 Oct 2026 -1.93%.
Dividends paidCash the company has paid per share, year by year.
2026 has paid ₹11.50 per share, about ₹754 on ₹1 lakh at today's price. Earlier years are restated to today's share count, so a bonus or split never reads as a dividend cut. Dividends are at the company's discretion and can be cut or skipped.
What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividendsHeld for 20 years this compounded at +22.4% a year. The last twelve months were up +3.0%. Price only, before dividends.
Who owns itThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Shareholding patternEach line is that holder's share of all shares over the last 7 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsAt a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Specialty Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
The business, year by yearSales and net profit by financial year or by quarter.
Sales and net profitWhere every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.
FY26In FY26, of every ₹100 of sales it kept ₹16.9 as profit. Other income added ₹1.8.
How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.
Compounded a yearWhere the cash wentProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
From the cash flow statementIn FY26 cash fell by ₹68 Cr, after ₹593 Cr spent on plant and equipment.
Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales in this financial year against the previous one. | 18.9% | 4.9% | 6.1% | 11.1% |
| Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax. | 16.8% | 21.9% | 22.9% | 24.1% |
| Net marginOf every ₹100 of sales in the year, how much was left as profit after everything. | 10.9% | 14.1% | 16.0% | 16.9% |
| ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | 17.3% | 21.8% | 22.6% | 23.5% |
| ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders. | 23.2% | 29.8% | 30.5% | 31.8% |
| Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | 0.02x | 0.02x | 0.01x | 0.01x |
| Interest coverHow many times the company's profit before interest could pay its interest bill. | 37.1x | 47.6x | 57.1x | 62.3x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Specialty Chemicals| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| PIDILITIND Pidilite Industries Limited | 1.55 L cr | 57.9x | 13.8x | 23.5% | 31.8% | 0.00 | 16.8% | +20.9% | 0.75% |
| SRF SRF Limited | 73,365 cr | 32.1x | 4.8x | 13.8% | 14.2% | 0.34 | 12.5% | +34.7% | 0.40% |
| FLUOROCHEM Gujarat Fluorochemicals Limited | 51,762 cr | 76.6x | 6.2x | 7.5% | 9.8% | 0.26 | 11.4% | +45.5% | 0.06% |
| NAVINFLUOR Navin Fluorine International Limited | 51,303 cr | 56.3x | 11.5x | 20.1% | 21.4% | 0.27 | 22.4% | +57.0% | 0.17% |
| AETHER Aether Industries Limited | 22,261 cr | 89.1x | 8.6x | 9.8% | 11.6% | 0.25 | 19.2% | +26.2% | 0.00% |
| DEEPAKNTR Deepak Nitrite Limited | 21,747 cr | 20.5x | 3.4x | 9.8% | 11.5% | 0.25 | 10.9% | +61.8% | 0.47% |
| AARTIIND Aarti Industries Limited | 17,475 cr | 29.4x | 2.8x | 7.3% | 7.0% | 0.82 | 5.6% | +74.7% | 0.21% |
| FINEORG Fine Organic Industries Limited | 16,248 cr | 33.7x | 5.5x | 16.8% | 22.0% | 0.05 | 18.5% | +22.1% | 0.21% |
| ATUL Atul Limited | 15,210 cr | 19.7x | 2.3x | 11.5% | 14.9% | 0.02 | 11.3% | +20.9% | 0.58% |
| ANURAS Anupam Rasayan India Limited | 14,807 cr | 82.1x | 2.9x | 5.8% | 7.4% | 0.34 | 8.9% | +10.2% | 0.12% |
| SUDEEPPHRM Sudeep Pharma Limited | 13,545 cr | 71.2x | 14.2x | 19.4% | 22.5% | 0.19 | 26.6% | +20.9% | 0.13% |
| PRIVISCL Privi Speciality Chemicals Limited | 13,198 cr | 35.4x | 8.4x | 24.8% | 22.2% | 0.61 | 13.4% | +12.0% | 0.44% |
| BASF BASF India Limited | 12,703 cr | 21.2x | 3.0x | 11.1% | 15.2% | 0.00 | 3.5% | +19.4% | 0.85% |
| VINATIORGA Vinati Organics Limited | 11,607 cr | 28.2x | 3.6x | 14.9% | 19.8% | 0.00 | 16.4% | +23.6% | 0.76% |
| ELANTAS Elantas Beck India Limited | 9,819 cr | 52.5x | - | - | - | - | 18.9% | +22.5% | 0.06% |
| JUBLINGREA Jubilant Ingrevia Limited | 9,424 cr | 26.6x | 2.8x | 9.2% | 11.0% | 0.27 | 7.1% | +24.4% | 0.85% |
| NEOGEN Neogen Chemicals Limited | 8,438 cr | 187.6x | 5.3x | 3.6% | 6.6% | 0.99 | 4.0% | +41.8% | 0.04% |
| ALKYLAMINE Alkyl Amines Chemicals Limited | 8,303 cr | 33.6x | 5.1x | 12.3% | 16.6% | 0.01 | 14.1% | +26.1% | 0.62% |
| GALAXYSURF Galaxy Surfactants Limited | 7,850 cr | 19.3x | 2.6x | 10.5% | 13.4% | 0.08 | 6.5% | +36.5% | 1.81% |
| CLEAN Clean Science and Technology Limited | 7,695 cr | 33.0x | 4.6x | 15.3% | 20.7% | 0.00 | 22.5% | +22.4% | 0.83% |
| BALAMINES Balaji Amines Limited | 6,205 cr | 26.1x | 3.0x | 7.9% | 10.4% | 0.07 | 14.6% | +37.3% | 0.57% |
| FCL Fineotex Chemical Limited | 6,192 cr | 37.2x | 6.3x | 14.9% | 18.3% | 0.01 | 13.2% | +181.5% | 0.09% |
| ACI Archean Chemical Industries Limited | 5,618 cr | 56.0x | 2.9x | 5.5% | 7.2% | 0.28 | 8.3% | +27.5% | 0.55% |
| PRASOLCHEM Prasol Chemicals Limited | 4,744 cr | - | 7.7x | - | - | 0.11 | - | - | 0.00% |
| FOSECOIND Foseco India Limited | 4,744 cr | 40.1x | 4.4x | 10.2% | 14.5% | 0.00 | 14.4% | +67.3% | 0.40% |
| YASHO Yasho Industries Limited | 4,439 cr | 51.3x | 8.7x | 5.8% | 9.1% | 1.20 | 7.8% | +89.7% | 0.01% |
| LXCHEM Laxmi Organic Industries Limited | 4,394 cr | 25.5x | 2.1x | 4.1% | 4.7% | 0.34 | 4.9% | +54.7% | 0.19% |
| EPIGRAL Epigral Limited | 4,101 cr | 14.4x | 1.7x | 16.1% | 15.7% | 0.24 | 10.2% | +27.0% | 0.53% |
| TATVA Tatva Chintan Pharma Chem Limited | 3,937 cr | 62.6x | 4.8x | 5.5% | 7.1% | 0.21 | 9.7% | +75.9% | 0.12% |
| CHEMPLASTS Chemplast Sanmar Limited | 3,745 cr | - | 2.4x | -14.6% | -3.6% | 1.11 | -7.6% | +28.1% | 0.00% |
| VISHNU Vishnu Chemicals Limited | 3,700 cr | 24.2x | 3.2x | 14.2% | 16.3% | 0.62 | 8.8% | +7.1% | 0.05% |
| STYRENIX Styrenix Performance Materials Limited | 3,315 cr | 13.2x | 2.2x | 14.4% | 15.9% | 0.16 | 6.8% | +24.4% | 2.44% |
| JUBLCPL Jubilant Agri and Consumer Products Limited | 2,783 cr | 26.5x | 5.3x | 32.6% | 41.1% | 0.33 | 5.1% | +15.0% | 0.00% |
| DDEVPLSTIK Ddev Plastiks Industries Limited | 2,530 cr | 11.6x | 2.3x | 21.8% | 31.1% | 0.06 | 6.3% | +43.8% | 0.72% |
| ROSSARI Rossari Biotech Limited | 2,415 cr | 15.8x | 1.7x | 11.8% | 14.7% | 0.26 | 5.7% | +19.0% | 0.11% |
| NOCIL NOCIL Limited | 2,348 cr | 30.1x | 1.3x | 3.1% | 4.4% | 0.00 | 5.3% | +33.2% | 1.07% |
| SHK S H Kelkar and Company Limited | 1,796 cr | 19.0x | 1.3x | 5.3% | 7.9% | 0.68 | 3.7% | +14.9% | 0.77% |
| INDOKEM Indokem Limited | 1,770 cr | 793.4x | - | - | - | - | 1.2% | +17.3% | 0.00% |
| OAL Oriental Aromatics Limited | 1,596 cr | 154.0x | 2.4x | 0.5% | 4.5% | 0.66 | 0.9% | +17.3% | 0.11% |
| NITTAGELA Nitta Gelatin India Limited | 1,573 cr | 15.2x | - | - | - | - | 17.5% | +1.5% | 0.40% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Month by monthThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Price return each month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.5 | +4.3 | -13.9 | +7.1 | +7.8 | +7.4 | +1.2 | +4.7 | -13.2 | -0.2 | +4.4 | · | +2.9% 11m |
| 2025 | -1.1 | -7.5 | +7.2 | +6.5 | +2.4 | -1.7 | -6.0 | +6.3 | -3.8 | -1.6 | +1.7 | +0.9 | +2.1% |
| 2024 | -6.7 | +8.0 | +10.2 | +1.1 | -2.6 | +6.4 | +0.9 | -2.0 | +7.6 | -6.4 | -2.5 | -5.3 | +7.0% |
| 2023 | -10.6 | +0.9 | +2.3 | +2.8 | +7.8 | -0.4 | +0.7 | -3.8 | -3.0 | +0.8 | +3.8 | +6.4 | +6.5% |
| 2022 | -0.3 | -2.2 | +2.1 | -1.3 | -7.4 | -6.9 | +17.3 | +11.6 | -1.7 | -3.9 | +6.4 | -7.2 | +3.5% |
| 2021 | -5.4 | +0.9 | +7.3 | +0.3 | +15.1 | +3.0 | +5.8 | +0.1 | +4.5 | -2.9 | -4.7 | +11.7 | +39.5% |
| 2020 | +9.0 | +0.1 | -10.4 | +12.6 | -3.8 | -6.6 | -1.1 | +3.4 | +2.2 | +9.5 | -1.8 | +14.5 | +27.3% |
| 2019 | +1.1 | +2.9 | +8.1 | -0.9 | +4.5 | -5.8 | +2.1 | +11.1 | +4.8 | -2.9 | -7.0 | +6.4 | +25.2% |
| 2018 | -0.7 | +0.5 | +1.9 | +18.4 | +6.6 | -8.1 | +5.6 | +4.0 | -10.5 | -8.3 | +21.3 | -4.8 | +22.8% |
| 2017 | +14.2 | +1.3 | +2.5 | +3.0 | +7.0 | +4.6 | -1.2 | +5.0 | -5.0 | -1.6 | +7.7 | +7.1 | +53.0% |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2022-11-14 | ISHARES CORE MSCI EMERGING MARKETS ETF · block | BUY | 2,54,509 | ₹2,661.20 | ₹67.73 Cr |
| 2022-11-14 | ISHARES CORE EMERGING MARKETS MAURITIUS CO · block | SELL | 2,54,509 | ₹2,661.20 | ₹67.73 Cr |
| 2022-11-03 | ISHARES CORE MSCI EMERGING MARKETS ETF · block | BUY | 2,54,510 | ₹2,634.45 | ₹67.05 Cr |
| 2022-11-03 | ISHARES CORE EMERGING MARKETS MAURITIUS CO · block | SELL | 2,54,510 | ₹2,634.45 | ₹67.05 Cr |
| 2022-10-03 | ISHARES CORE MSCI EMERGING MARKETS ETF · block | BUY | 2,10,534 | ₹2,690.30 | ₹56.64 Cr |
| 2022-10-03 | ISHARES CORE EMERGING MARKETS MAURITIUS CO · block | SELL | 2,10,534 | ₹2,690.30 | ₹56.64 Cr |
| 2022-08-08 | ISHARES MSCI INDIA ETF · block | BUY | 1,80,067 | ₹2,640.85 | ₹47.55 Cr |
| 2022-08-08 | ISHARES INDIA INDEX MAURITIUS COMPANY · block | SELL | 1,80,067 | ₹2,640.85 | ₹47.55 Cr |
- Board outcomeOutcome of Board Meeting28 Oct 2026
Pidilite Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting4 Aug 2026
Pidilite Industries Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
- Board outcomeOutcome of Board Meeting7 May 2026
Pidilite Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Board outcomeOutcome of Board Meeting3 Feb 2026
Pidilite Industries Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
- Board outcomeOutcome of Board Meeting30 Oct 2025
Pidilite Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
- Board outcomeOutcome of Board Meeting6 Aug 2025
Pidilite Industries Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
- Integrated Filing- Financial11 Feb 2025
Intimation under Regulation 30 of the SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015 - Integrated Filing (Financial) for thequarter and nine months period ended 31st December, 2024
- Financial Result Updates22 Jan 2025
Pidilite Industries Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test PIDILITIND. “Buy PIDILITIND when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free